New PREVENT-ASCVD Equations: Replaces the older Pooled Cohort Equations for 10- and 30-year cardiovascular risk assessment in adults aged 30 to 79. [1] (https://professional.heart.org/en/science-news/2026-guideline-on-the-management-of-dyslipidemia/top-things-to-know)Reinstated LDL-C & Non-HDL Goals: Treatment targets return to guide therapy intensity:<100 mg/dL for primary prevention in borderline/intermediate risk.<70 mg/dL for high-risk individuals.<55 mg/dL for very high-risk secondary prevention patients. [1] (https://newsroom.heart.org/news/accaha-issue-updated-guideline-for-managing-lipids-cholesterol), [2] (https://www.acc.org/latest-in-cardiology/articles/2026/06/15/14/16/implications-of-the-2026-multisociety-dyslipidemia-guideline), [3] (https://www.jacc.org/guidelines/dyslipidemia), [4] (https://professional.heart.org/en/science-news/2026-guideline-on-the-management-of-dyslipidemia/top-things-to-know)Lipoprotein(a) [Lp(a)] Testing: Recommended at least once in a lifetime for adults to detect inherited cardiovascular risks
New PREVENT-ASCVD Equations: Replaces the older Pooled Cohort Equations for 10- and 30-year cardiovascular risk assessment in adults aged 30 to 79. [1] (https://professional.heart.org/en/science-news/2026-guideline-on-the-management-of-dyslipidemia/top-things-to-know)Reinstated LDL-C & Non-HDL Goals: Treatment targets return to guide therapy intensity:<100 mg/dL for primary prevention in borderline/intermediate risk.<70 mg/dL for high-risk individuals.<55 mg/dL for very high-risk secondary prevention patients. [1] (https://newsroom.heart.org/news/accaha-issue-updated-guideline-for-managing-lipids-cholesterol), [2] (https://www.acc.org/latest-in-cardiology/articles/2026/06/15/14/16/implications-of-the-2026-multisociety-dyslipidemia-guideline), [3] (https://www.jacc.org/guidelines/dyslipidemia), [4] (https://professional.heart.org/en/science-news/2026-guideline-on-the-management-of-dyslipidemia/top-things-to-know)Lipoprotein(a) [Lp(a)] Testing: Recommended at least once in a lifetime for adults to detect inherited cardiovascular risks
Created using ChatSlide
This initiative focuses on modernizing cardiovascular risk assessment by utilizing the PREVENT-ASCVD tool for evaluating 10- and 30-year risks in adults aged 30-79. It emphasizes restoring LDL-C and Non-HDL-C targets, aiming for specific levels based on risk categories. Additionally, it advocates for the detection of hidden risks through Lp(a) measurement in all adults, refining prevention strategies by incorporating inherited risk factors and fostering collaborative decision-making.